| |
| |
|
| Insider
Information: |
Quimi Daphne |
| Relationship: |
|
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
403,532 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,228,425 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
403,532 |
|
|
| Total
Value |
$4,228,425 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
Chief Financial Officer |
2023-01-18 |
398,532 |
2014-04-10 |
0 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-05-15 |
5,000 |
2024-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2014-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2014-09-29 |
4 |
AB |
$6.10 |
$65,465 |
D/D |
10,738 |
60,738 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2014-09-29 |
4 |
AS |
$6.10 |
$65,465 |
D/D |
(10,738) |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2014-10-03 |
4 |
AB |
$7.00 |
$47,684 |
D/D |
6,812 |
56,812 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2014-10-03 |
4 |
AS |
$7.00 |
$47,684 |
D/D |
(6,812) |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2014-11-25 |
4 |
AS |
$8.00 |
$28,000 |
D/D |
(3,500) |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2014-11-25 |
4 |
AB |
$8.00 |
$28,000 |
D/D |
3,500 |
53,500 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2015-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2015-05-08 |
4 |
D |
$10.80 |
$100,570 |
D/D |
(9,312) |
15,688 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2015-05-11 |
4 |
AS |
$10.84 |
$81,306 |
D/D |
(7,500) |
8,188 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Vice President Finance |
• – – |
2015-07-01 |
4 |
AS |
$13.98 |
$36,350 |
D/D |
(2,600) |
8,188 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Vice President Finance |
• – – |
2015-07-01 |
4 |
OE |
$13.98 |
$36,350 |
D/D |
2,600 |
10,788 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Vice President Finance |
• – – |
2015-09-14 |
4 |
AS |
$18.08 |
$45,200 |
D/D |
(2,500) |
5,688 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Vice President Finance |
• – – |
2015-10-01 |
4 |
OE |
$13.13 |
$147,761 |
D/D |
11,250 |
16,938 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Vice President Finance |
• – – |
2015-10-01 |
4 |
AS |
$13.13 |
$147,761 |
D/D |
(11,250) |
5,688 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,500 |
29,877 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2016-11-09 |
4 |
OE |
$8.00 |
$22,864 |
D/D |
2,858 |
27,047 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2016-11-09 |
4 |
AS |
$8.00 |
$68,368 |
D/D |
(8,546) |
24,189 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,487 |
54,676 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2017-10-12 |
4 |
AS |
$14.25 |
$99,740 |
D/D |
(7,000) |
54,676 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2017-10-12 |
4 |
OE |
$14.25 |
$99,740 |
D/D |
7,000 |
61,676 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2018-01-02 |
4 |
OE |
$14.72 |
$117,723 |
D/D |
8,000 |
62,676 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2018-01-02 |
4 |
AS |
$14.72 |
$117,723 |
D/D |
(8,000) |
54,676 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2018-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,609 |
67,285 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2018-01-03 |
4 |
D |
$15.67 |
$46,274 |
D/D |
(2,953) |
64,332 |
0 |
- |
|
80 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
